The Premier Audio Journal
by the American College of Cardiology

A proud part of the American College of Cardiology’s distinguished educational portfolio, ACCEL is the premier cardiovascular audio journal, carefully and intuitively designed to help you stay current and meet all your learning needs.

This audio journal delivers short, CME-certified interviews, revealing insights beyond the published data that only conversations between experts could uncover. These vital updates from key cardiology conferences and recently published authors are all available whenever and wherever you choose.

ACCEL Audio Journal Logo from the American College of Cardiology




Explore ACCEL

Listen to interviews on breaking research in Cardiology

Just in Time From JACC: Survival After Implantable Cardioverter Defibrillator Therapy
Mehmet K. Aktas, MD, Associate Professor of Medicine, University of Rochester Medical Center, Rochester, NY

Interviewer: Gerald V. Naccarelli, MD, FACC, Bernard Trabin Chair in Cardiology, Professor of Medicine, Chief Division of Cardiology, Associate Clinical Director Penn State Heart and Vascular Institute, Penn State University College of Medicine–Hershey, Hershey, PA

Correspondent: Zain Ul Abideen Asad, MD, Assistant Professor of Medicine, Cardiovascular Section, University of Oklahoma Health Sciences Center, Oklahoma City, OK

Study findings suggest that survival among patients with fast and dangerous heart rhythms who undergo implantable cardioverter defibrillator therapy is adversely affected by underlying mechanisms rather than by the shock therapy itself. Treatments focused on modifying the mechanisms that lead to fast and dangerous heart rhythms may improve survival in such patients.

ACC.21 Late Breaker: Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction: Results of the Life Trial
Douglas L. Mann, MD, Lewin Distinguished Professor of Cardiovascular Disease, Washington University, St. Louis, MO

Interviewer: Sean P. Pinney, MD, FACC, Adjunct Professor, Mount Sinai Hospital, New York, NY

Correspondent: Michelle D. Kelsey, MD, Fellow in Training, Duke University, Durham, NC

This study will help clinicians to understand the safety and efficacy of sacubitril/valsartan in patients with advanced heart failure.

Choose the Membership tailor-made for you

Fellows in
Training

Approximately 20 brand new ACCEL interviews and debates monthly.


Starting from:
FREE

Cardiovascular
Team

Approximately 20 brand new ACCEL interviews and debates monthly.


Starting from:
$199

Silver
Membership

Approximately 20 brand new ACCEL interviews and debates monthly.


Starting from:
$399

Gold
Membership

Approximately 20 brand new ACCEL interviews and debates monthly, plus access to 600+ interviews from the past 3 years.

Starting from:
$599

Platinum
Membership

Approximately 20 brand new ACCEL interviews and debates monthly, plus access to every AudioDigest lecture, across every specialty.

Starting from:
$1,499


Subscribe

ACCEL Lite Podcast 

ACCEL Lite Podcast

Listen to interesting interviews, news and more!



Stay Up-to-date with ACCEL Audio Journal


ACCEL provides direct access to the researchers who share backstories and perspective that is unlike any other product. It includes actionable content that’s highly relevant to not only physicians, but today’s comprehensive cardiovascular care team — and translates directly into improved patient care. You will be able to implement new learnings in real–world practice, access convenient, on-the-go cardiovascular education, and stay up–to–date with the latest and greatest in the ever-expanding field of cardiology.

This engaging content includes new interviews and insider discussions covering current, clinically relevant, evidence-based information, insight, and updates. Each interview qualifies for AMA PRA Category 1 Credits™ and ABIM Part II Maintenance of Certification (MOC) Points (Nov 2016 and newer issues).

The ACCEL app makes it easier than ever to stay up–to–date with the latest cardiology news. Subscribe today.

Welcoming New ACCEL Editor-in-Chief
Alison L. Bailey, MD FACC
ACCEL Editor-in-Chief Alison L. Bailey, MD FACC




View
Your
Offer

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. For information on cookies and how you can disable them visit our Privacy and Cookie Policy.   Agree